ORMP:NASDAQ
Oramed Pharmaceuticals, Inc.
$4.03
arrow_downward
-0.98%(-0.040) 1D
Oct 19, 11:08:30 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORMP...
Open
$4.08
High
$4.08
Low
$3.89
Mkt. cap
167.64M
Avg. vol.
171.83K
Volume
74.56K
P/E ratio
0.98
52-wk high
$5.47
52-wk low
$2.09
EPS
$4.13
Beta
1.29
Shares outstanding
41.60M
No. of employees
13
Open
$4.08
High
$4.08
Low
$3.89
Mkt. cap
167.64M
Avg. vol.
171.83K
Volume
74.56K
P/E ratio
0.98
52-wk high
$5.47
52-wk low
$2.09
EPS
$4.13
Beta
1.29
Shares outstanding
41.60M
No. of employees
13
News stories
From web sources and news partners
BigGo Finance
·
45 minutes ago
S&P 500, Nasdaq Climb at Open as AI Stocks Rebound; Dow Slips
RealMoney Pro
·
40 minutes ago
Charting the Markets: The S&P Is Still Bullish. But for How Long?
GuruFocus
·
42 minutes ago
Bank of America Securities Upgrades Dow Inc. (DOW) to Neutral on Rising Chemical Prices
TradingView
·
1 hour ago
The Dow Jones Index Opens 0.08% Lower
Profile
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
About Oramed Pharmaceuticals, Inc.